Evaluation of therapeutic efficacy of Cetorolaco Trometamol in comparison of Physiotherapic treatment in patients with Temporomandibular Dyfunction

niversidade Federal do Ceará0 个研究点开始时间: 2019年12月12日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients of both sexes, from 18 to 50 years old;
•Diagnosis of Temporomandibular Joint / Muscular Dysfunction (TMD), with pain for at least 60 or 90 days, confirmed after clinical evaluation by a dental professional;
•Patient examined and considered in good health, according to medical judgment, without severe comorbidities; Patient is able to understand the nature and purpose of the study, including the risks and adverse effects and with the intention to cooperate with the researcher and to act in accordance with the requirements of the entire protocol, which is confirmed by signing the Terms of Reference. Informed Consent, performed before any procedure.

•Patient has known hypersensitivity to non-steroidal anti-inflammatory drugs or a history of serious adverse reactions to any medicinal product. Body mass index (BMI) less than 18 or greater than 30; Current or recent history (within the last 12 months) of drug, drug or alcohol abuse; He was hospitalized for any reason for four weeks prior to the start of the study; Patients with a clinical history of serious heart, kidney, liver and lung disorders; Pregnant and / or nursing women; Patient undergoing specific treatment (orthodontic) for TMD at least 02 months; Patient using any medication with analgesic and / or anti-inflammatory action that cannot be suspended during the wash out period, which corresponds to 5 times the half-life of the drug; Participation in any experimental study or ingestion of any experimental drug three months prior to commencement of this study; EVA less than 05; Has any condition that the investigator deems relevant for non-participation in the study.

发起方

niversidade Federal do Ceará